Published: · Last reviewed:
Should I Take a GLP-1 Pill or Injection?
Short answer before everything else
Lean toward an injection if your #1 goal is the most weight loss. The strongest shot (Zepbound) reached about 20% average weight loss — more than any pill.
Lean toward a pill if needles, travel, or cost would stop you from starting at all. The two FDA-approved weight-loss pills (the Wegovy pill and Foundayo) genuinely work, with roughly 12% to 17% average weight loss depending on the option.
But the “right” answer flips based on five things most articles skip — your morning routine, your insurance, your budget, your medical history, and how much a needle really bothers you.
A pill may fit you best if:
- Needles are a real barrier
- You travel often
- You want the lowest cash price to start
- You want a quieter routine
An injection may fit you best if:
- You'd rather dose once a week than every day
- You don't want morning timing rules
- You want the strongest weight-loss results on record
Don't choose on format alone if:
- You have diabetes or heart disease
- History of pancreatitis or gallbladder issues
- Plans to get pregnant
- Personal/family history of medullary thyroid cancer or MEN 2
Major FDA-approved GLP-1 weight-loss pills and injections (2026)
Last verified June 2026. “Avg. weight loss” is from each drug's main clinical trial. Cash prices are public medication-only floors and don't include provider visits, membership, or labs.
| Medication | Pill or shot? | Avg. weight loss (trial) | Daily food/water rule? | Cash price floor / mo* |
|---|---|---|---|---|
| Zepbound (tirzepatide) | Shot — weekly | ~20–22.5% (SURMOUNT-1) | No | ~$299–$449 |
| Wegovy HD (semaglutide 7.2 mg) | Shot — weekly | ~21% (STEP UP) | No | ~$399 |
| Wegovy pill (oral semaglutide 25 mg) | Pill — daily | 16.6% if taken consistently; 13.6% overall (OASIS 4) | Yes — empty stomach, plain water, wait 30 min | ~$149–$299 |
| Wegovy (semaglutide 2.4 mg) | Shot — weekly | ~14–15% (STEP 1) | No | ~$199–$349 |
| Foundayo (orforglipron) | Pill — daily | ~12.4% at highest dose (ATTAIN-1) | No — any time, with or without food | ~$149–$349 |
*Prices change often and vary by dose. The pricing section below shows the details and caveats. Other medications: Saxenda (liraglutide) is an older daily injection with about 8% average loss. Ozempic tablets are a semaglutide pill approved for type 2 diabetes, not weight loss.
One honest note on these numbers:
Only the Zepbound-vs-Wegovy result came from a true head-to-head study (SURMOUNT-5, where tirzepatide beat semaglutide 20.2% to 13.7%). The rest come from separate trials with different patients — treat them as strong signals, not a photo finish.
Personalized format, medication, and provider · source-verified pricing
Is the GLP-1 pill as effective as the injection?
Not quite — but it's closer than the old reputation suggests. The strongest shot, Zepbound (tirzepatide), still beats every pill, with about 20% average weight loss in trials. The strongest pill, the Wegovy pill, reached 16.6% in people who stuck with it. So the gap is real, but smaller than “pills barely work” makes it sound. And here's the thing almost no other page tells you: “pill vs injection” is the wrong frame. What actually drives your results is which drug and at what dose — not the delivery method.
Tirzepatide (Zepbound) is the heavy hitter
It's the only option that works on two hunger hormones at once — GLP-1 and GIP (both are natural gut hormones that tell your brain you're full). That dual action is why it leads, and it only comes as a weekly shot.
Semaglutide is semaglutide — pill or shot, it's close
The oral semaglutide pill (16.6% if taken consistently) and the semaglutide injection (about 14–15%) landed in similar territory in their separate trials. These weren't head-to-head studies, so we won't claim one beat the other. But it means the semaglutide pill is not a consolation prize. It's a serious option.
Orforglipron (Foundayo) trades a little power for total convenience
At about 12.4% it's the lowest of the approved weight-loss drugs here — but it's the only pill with zero food or water rules. You give up a few points and get the easiest routine on the list.
How to read these numbers honestly:
“Head-to-head” means two drugs were tested against each other in the same study — only Zepbound vs Wegovy was (SURMOUNT-5). “Separate trial” means the number is real but came from a different study with different people, so small gaps don't prove much. “If taken consistently” (the Wegovy pill's 16.6%) means the result for people who actually stuck with it — the “overall” 13.6% counts everyone including people who missed doses.
The honest thing: if your only goal is to lose the absolute most weight, a pill is not your best move. Zepbound's roughly 20% beats the best pill result, and no pill matches it yet. If maximum weight loss is the one thing you care about — and you can handle a weekly shot — the injection is the better path. Don't let nerves talk you out of results.
But for most people reading this, that's not the whole story. The approved pills work. The Wegovy pill's 16.6% is real, meaningful weight loss. And here's what matters more than a few percentage points: the best medication is the one you'll actually take. A shot you dread and skip does nothing. A pill you take every morning beats a pen sitting unused in your fridge. If needles are the reason you haven't started, the pill isn't a cop-out — it's the thing that finally gets you going.
Get your personalized match · free · no email
What GLP-1 pills and injections are FDA-approved in 2026?
In 2026 there are two FDA-approved weight-loss pills — the Wegovy pill (oral semaglutide) and Foundayo (orforglipron) — plus several FDA-approved injections, including Wegovy, the higher-dose Wegovy HD, and Zepbound. Ozempic now comes as a tablet too, but it's approved for type 2 diabetes, not weight loss.
FDA-approved weight-loss pills:
- Wegovy pill (oral semaglutide 25 mg) — approved December 22, 2025. Made by Novo Nordisk. Daily, taken on an empty stomach.
- Foundayo (orforglipron) — approved April 1, 2026. Made by Eli Lilly. Daily, with no food or water rules. It's a “small molecule” drug built differently than semaglutide, so it survives your stomach without special timing.
FDA-approved weight-loss injections:
- Wegovy (semaglutide 2.4 mg) — the original weekly shot.
- Wegovy HD (semaglutide 7.2 mg) — a higher-dose version approved March 2026 for certain adults.
- Zepbound (tirzepatide) — the weekly shot with the strongest results.
Names that cause confusion:
- “Is there a pill version of Ozempic?” Yes — but not for weight loss. In February 2026 the FDA approved Ozempic tablets (1.5 mg, 4 mg, 9 mg), replacing the older Rybelsus brand. These are approved for adults with type 2 diabetes, not weight management. For an FDA-approved semaglutide pill for weight loss, the product is the Wegovy pill — same maker, same active ingredient, different dose and approved use.
- Ozempic and Mounjaro injections are diabetes brands. For an FDA-approved weight-loss path, the names above are what you want.
Which is easier to live with — a daily pill or a weekly shot?
It depends on which barrier is bigger for you: the needle or the daily routine. A pill removes the needle but can add strict morning timing. A weekly injection skips the daily habit but asks you to be okay with a shot. Foundayo is the most flexible pill (no timing rules), the Wegovy pill is the most demanding (a 30-minute fast), and injections are once a week but need some device handling and storage planning.
The Wegovy pill: no needle, but real rules
You take it once a day, first thing in the morning, on an empty stomach, with no more than 4 ounces (about half a cup) of plain water. Then you wait at least 30 minutes before eating, drinking anything else, or taking other pills.
Why so strict? Because semaglutide is a fragile molecule. Swallowed normally, less than 1% of it actually reaches your bloodstream — your stomach destroys the rest. The empty-stomach rule and a special absorption helper inside the pill are what let any of it work. Miss the routine and you're wasting the dose. For a coffee-first person, this fights your habits every single day.
Foundayo: the easy-routine pill
Foundayo is also a daily pill, but Lilly built it to survive your stomach without the drama. No empty stomach. No water limit. No 30-minute wait. Any time of day, with or without food. That's its whole pitch: a bit less weight loss than the strongest options, traded for the simplest routine on this list. If the Wegovy pill's fasting rule sounds impossible for your life, this is usually the pill to ask about.
The weekly injection: one habit, then you're done
Most GLP-1 shots are once a week, any time of day, food or no food. You pick a “shot day,” use a pen with a tiny needle (usually in the belly, thigh, or upper arm), and you're set for seven days. No daily timing, no fasting. The trade-offs: you need to be okay with a small self-injection, and pens need some storage planning — many are kept refrigerated but can sit at room temperature for a limited time, which makes travel manageable if you check your specific product's label.
What people actually struggle with
| Real friction point | What it means for your format choice |
|---|---|
| Needle fear is the #1 reason people reach for the pill | For some, it's not preference — it's "if it's a shot, I won't do it." That's valid, and it's exactly what the pills are for. |
| Some people find the daily pill harder than a weekly shot | Ten seconds once a week beats a fasting ritual every morning, for a lot of folks. |
| The coffee problem is real | People who wake up and need caffeine immediately often can't make the Wegovy pill's timing work — and end up preferring Foundayo or a shot. |
| Travel and discretion matter | Pills are easy to toss in a bag. Pens take a little more planning. |
Forum sentiment is reader experience, not medical evidence. It doesn't predict your results or your safety.
The takeaway: pick the one you'll still be doing correctly eight weeks from now. Honesty with yourself here beats a few percentage points on paper.
Free match · no signup required
Which costs less — a GLP-1 pill or injection?
Paying cash, the pills are usually the cheaper way to start — the Wegovy pill and Foundayo both begin around $149 a month for the lowest dose, versus about $199–$349 for the Wegovy injection and $299–$449 for Zepbound. But insurance can flip this completely, savings cards can drop eligible patients to as low as $25 a month, and the medication price is only part of your total cost.
Medication-only cash prices (June 2026 — recheck before relying on them)
| Medication | Form | Cash price floor / mo | Notes |
|---|---|---|---|
| Wegovy pill | Pill | from ~$149 (low doses) to ~$299 (high doses) | Lowest cash entry point |
| Foundayo | Pill | ~$149–$349 by dose | Some high doses ~$299 with Lilly's refill-timing offer |
| Wegovy injection | Shot | ~$199 starter through June 30, 2026, then ~$349 | Weekly |
| Wegovy HD injection | Shot | ~$399 | Higher-dose 7.2 mg |
| Zepbound | Shot | ~$299 (2.5 mg) / ~$399 (5 mg) / ~$449 (higher, with Lilly refill program) | Up to ~$699 at higher doses outside the refill program |
Will insurance cover a GLP-1 pill or injection?
Insurance can matter more than pill versus injection. Many plans cover one FDA-approved GLP-1 but not another, most require prior authorization, and Medicare access is handled separately. Check your coverage before you choose based on cash prices alone.
- Commercial insurance + manufacturer savings cards can bring eligible patients to as low as $25/month for some of these drugs.
- Medicare (starting July 1, 2026): eligible Medicare Part D beneficiaries may be able to get select FDA-approved GLP-1s for weight loss — all forms of Foundayo and Wegovy (pills and injections), plus the Zepbound KwikPen — for a flat $50/month copay through the Medicare GLP-1 Bridge, with prior authorization. The single-dose Zepbound vial and single-dose pen are not included, and the $50 copay doesn't count toward your Part D deductible. Ask your provider if you qualify.
Ro carries the FDA-approved options — including Zepbound and Foundayo — matches LillyDirect and NovoCare pricing, handles prior-authorization paperwork through an insurance concierge, and has a free GLP-1 coverage checker. Get started for $39, then as low as $74/month with the annual plan paid upfront.
Check current pricing on Ro → (sponsored affiliate link, opens in a new tab)Affiliate link · medication priced separately
Prefer to compare providers, or have a Costco membership? Sesame Care is a solid second option for self-pay branded pricing.
Compare on Sesame Care → (sponsored affiliate link, opens in a new tab)Affiliate link
Do GLP-1 pills have fewer side effects than injections?
No — not in any meaningful way. The most common side effects (nausea, diarrhea, vomiting, constipation) come from the GLP-1 medication itself, so they show up with pills and injections alike. What matters most is how slowly your dose is raised — plus the specific drug and your health history — not whether you swallow it or inject it.
The side effects every GLP-1 shares
Because they all slow digestion and dial down appetite, they cause similar issues: nausea, vomiting, diarrhea, constipation, stomach pain, and lower appetite. Most are mild to moderate and ease up as your body adjusts. The single biggest factor in how rough this feels is titration — starting at a low dose and stepping up slowly. A patient dose schedule beats format every time.
The serious warning they share
Every drug on this page carries a boxed warning (the FDA's strongest warning label) about a rare risk of thyroid C-cell tumors, based on animal studies, and all are not for people with a personal or family history of medullary thyroid cancer or MEN 2. Each drug also has its own cautions around pancreatitis, gallbladder problems, kidney issues, and low blood sugar if combined with certain diabetes meds. A real prescriber needs to screen you. This isn't a casual online purchase.
A pill-specific detail most pages miss
Straight from Foundayo's prescribing information: Foundayo may make oral hormonal birth control less effective. The label advises patients on oral contraceptives to switch to a non-oral method or add a barrier method for 30 days after starting Foundayo and for 30 days after each dose increase. The label also says not to exceed simvastatin 20 mg per day (a common cholesterol drug) while taking Foundayo. If either applies to you, raise it with your doctor before you start.
And a rule for everyone: don't stack GLP-1s. Wegovy's own prescribing information says not to use it with other semaglutide products or other GLP-1 medications. One at a time, under a prescriber's care.
The RX Index Pill-or-Injection Fit Guide
Start with your single biggest priority, not the average patient's. Find your top priority on the left; read your honest recommendation on the right.
| If your #1 priority is… | Lean toward… | Why | The trade-off to accept |
|---|---|---|---|
| The most weight loss | An injection — Zepbound | Highest trial results (~20%+); dual-hormone action | Weekly shot; tirzepatide is injection-only |
| No needles, period | A pill — Foundayo or Wegovy pill | Both FDA-approved, needle-free, effective | A bit below the top injections; Wegovy pill adds the fasting rule |
| The simplest daily routine | Foundayo | Once daily, any time, food or no food | ~12.4% is the lowest of the approved options |
| A "once and done" weekly habit | An injection | One dose a week; nothing daily to remember | You handle a small shot and some storage planning |
| The strongest pill results | Wegovy pill | Best trial result of any pill (16.6%) | The strict morning empty-stomach + 30-min fast |
| The lowest cash price | A pill (from ~$149/mo) | Cheapest cash entry point | Insurance can change this entirely |
| Using insurance or Medicare | Let your formulary decide | Coverage varies widely; concierge help matters more than format | Prior auth takes time; Medicare Bridge starts July 2026 |
| Avoiding GI side effects | Neither format wins | Nausea is a class effect; slow titration matters most | Be patient with the dose ramp-up |
A quick reality check on the two pills:
- Choose the Wegovy pill if you can genuinely follow a morning fasting routine and you want the strongest pill results.
- Choose Foundayo if you cannot picture delaying your coffee, breakfast, or other morning meds — the flexibility is worth more to you than the last couple of percentage points.
Verified pricing for your state and insurance
Already sure you want an FDA-approved option?
See it on Ro → (sponsored affiliate link, opens in a new tab)Affiliate link
What about compounded GLP-1 pills, drops, and gum?
Compounded semaglutide and tirzepatide are sold by some telehealth sites in pills, drops, lozenges, and other forms, often at lower prices — but they are not FDA-approved, their strength and quality aren't FDA-verified, and the legal ground is shifting fast right now. For a clean pill-vs-injection decision, the most reliable path is to compare the FDA-approved options above.
What “compounded” means
A compounded medication is mixed by a pharmacy. It is not an FDA-approved finished drug. That's not the same as “illegal” or “always bad,” but it is a real difference. We will never tell you a compounded pill is the same as the Wegovy pill or Foundayo — because it isn't. The FDA has warned about dosing errors, illegal online sales, and unapproved salt forms in some compounded GLP-1 products, and has logged hundreds of adverse-event reports tied to compounded semaglutide and tirzepatide.
The legal status is changing fast
Compounding boomed when these drugs were in shortage. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025. In a Federal Register notice published May 1, 2026, the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the “503B Bulks List” — finding “no clinical need.” Public comments were due June 30, 2026, and a final decision follows. Online compounded GLP-1 availability can change quickly.
If you're specifically drawn to a compounded path, read our is compounded GLP-1 still available? guide first — and use the quiz so a real provider reviews whether it's appropriate for you. Don't buy a “GLP-1 pill” ad without knowing exactly what's in it.
Keeps FDA-approved and compounded options clearly separate
Can you switch from a shot to a pill (or start with one and switch later)?
Yes — switching between formats is common, but it should be done with a prescriber, who'll re-start you at an appropriate dose rather than matching milligram-for-milligram. The doses aren't equal across drugs and formats. People switch for cost, convenience, side effects, needle fatigue, or to step up to a stronger option.
| Good reasons to ask about switching | Reasons not to switch on autopilot |
|---|---|
|
|
Starting with a pill, then switching up, can make sense if a needle is the only thing keeping you from starting at all — begin where you'll actually begin, then revisit with your provider. There's also early Phase 3 evidence that people switching from an injectable to oral orforglipron (Foundayo) held on to much of their earlier weight loss — encouraging, though it doesn't mean every switch follows the same plan. If your clinician thinks an injection is the better fit for your goals or health history, don't use the pill as a way to avoid that conversation.
Questions to bring to your prescriber about switching
- Would switching change my dose schedule, or need a gap?
- What side effects should I expect during the change?
- Would my insurance cover the new option?
- Could my other medications interfere with a pill's timing?
- What's the plan if the new option doesn't work as well?
How we built this comparison
We pulled every weight-loss number from each drug's published clinical trial (SURMOUNT, STEP, OASIS, ATTAIN), every approval date from the FDA or the manufacturer, and every price from the provider's or maker's current pricing page. We keep FDA-approved and compounded options strictly separate. We don't prescribe or sell medication — we're an independent decision resource.
What we actually verified (June 2026) — expand to see
- FDA approval dates: Wegovy pill (Dec 22, 2025), Foundayo (April 1, 2026), Wegovy HD (March 2026), Ozempic tablets for type 2 diabetes (Feb 4, 2026) — FDA / manufacturer announcements
- Trial weight-loss results: SURMOUNT-1 & SURMOUNT-5 (NEJM), STEP 1, STEP UP, OASIS 4, ATTAIN-1 — peer-reviewed journals / FDA labels
- Dosing & routine rules for the Wegovy pill and Foundayo — official prescribing information
- Cash prices: Ro, LillyDirect, NovoCare — checked June 2026
- Compounding status: FDA 503B Bulks List proposal (Federal Register, May 1, 2026), comments due June 30, 2026
- Medicare GLP-1 Bridge drug list, $50 copay, and dates — CMS
Not verified here: live checkout screenshots, state-by-state availability, your individual insurance formulary, and whether you specifically will be prescribed a medication (always clinician-decided). Prices change often — re-check before relying on them.
GLP-1 pill vs injection: FAQ
The short version: choose the format you can stick with, that fits your coverage and budget, and that your prescriber agrees is right for your health.
Is the GLP-1 pill as effective as the shot?
Some FDA-approved pills now show meaningful weight loss — the Wegovy pill reached 16.6% in people who stayed on it — but the strongest injections (Zepbound at about 20%+, Wegovy HD around 21%) still lead. These come from separate trials, not head-to-head studies, so the honest answer is to compare options with a prescriber rather than assume one number is yours.
Is there a pill version of Ozempic?
Yes, but not for weight loss. The FDA approved Ozempic tablets (1.5, 4, and 9 mg) in February 2026 for adults with type 2 diabetes, and they're replacing the older Rybelsus brand. The semaglutide pill approved for weight management is the Wegovy pill — same maker and active ingredient, but a different dose and approved use.
Is the Wegovy pill the same as the Wegovy shot?
Both are semaglutide, but they're different products with different routines. The Wegovy pill is daily and must be taken on an empty stomach with a 30-minute wait; the Wegovy injection is once weekly with no fasting rule.
How much weight can you lose on the GLP-1 pill?
In trials, the Wegovy pill averaged 16.6% body-weight loss in people who stayed on treatment (13.6% counting everyone), and Foundayo averaged about 12.4% at its highest dose. Individual results vary, and these numbers come with diet and activity changes alongside the medication.
Why do you have to take the Wegovy pill on an empty stomach?
Because semaglutide is fragile — less than about 1% survives digestion normally. Taking it on an empty stomach with a sip of water, then waiting 30 minutes, is what lets enough of it absorb to work. Foundayo doesn't have this rule because it's built differently.
Do GLP-1 pills cause fewer side effects than injections?
No meaningful difference. Nausea, diarrhea, and other stomach effects come from the medication itself, not the delivery method. How slowly your dose is raised, plus the specific drug and your health history, matters far more than pill versus shot.
Are compounded GLP-1 pills FDA-approved?
No. Compounded products are not FDA-approved finished drugs, and the FDA has raised concerns about dosing errors and illegal online sales. Don't treat a compounded oral GLP-1 as equal to the Wegovy pill or Foundayo.
Which is cheaper without insurance, a GLP-1 pill or injection?
Paying cash, the pills usually start lower (around $149/month) than the injections ($199 to $449/month, and up to about $699 for the highest Zepbound doses outside the refill program). But your true cost depends on dose, the program's membership fee, and refill timing — compare the full monthly total, not just the headline drug price.
Can I switch from the shot to the pill?
Yes, with your prescriber's guidance. You'll typically re-start at an appropriate dose rather than matching your old one exactly, and you'll want to confirm coverage and check for any interactions first.
Does Medicare cover a GLP-1 pill or injection for weight loss?
Starting July 1, 2026, eligible Medicare Part D beneficiaries can access certain weight-loss GLP-1s through the Medicare GLP-1 Bridge for a flat $50/month copay — all forms of Foundayo and Wegovy (pills and injections), plus the Zepbound KwikPen. Prior authorization is required, and the single-dose Zepbound vial and pen aren't included.
Should I choose the injection if I want the most weight loss?
If maximum weight loss is your top priority, an injection — especially tirzepatide (Zepbound) — is the stronger conversation to have. Results vary by person, and not everyone is eligible for or tolerates every option.
What if I still can't decide?
Use The RX Index's Find My GLP-1 Path tool. Answer a few questions about needles, your morning routine, insurance, and budget, and you'll get a personalized starting point with source-verified pricing before you pick a provider.
The bottom line
Choosing between a GLP-1 pill and an injection isn't really a contest between “strong” and “weak.” It's a match between what works and what you'll actually do. If you want the most weight loss and can handle a weekly shot, the injection wins. If a needle, your schedule, or the price would keep you on the sidelines, the approved pills are real, doctor-backed options that genuinely work — and the one you'll stick with beats the one you abandon every time.
Whatever you choose, confirm it with a licensed prescriber. They'll factor in your health history, your medications, and your coverage — the things a chart can't.
Find My GLP-1 Path · personalized recommendation · no email required
Sources
- FDA / Eli Lilly — Foundayo (orforglipron) approval, April 1, 2026; ATTAIN-1 results; Foundayo prescribing information (contraceptive and simvastatin guidance). investor.lilly.com; fda.gov; DailyMed
- Novo Nordisk — Wegovy pill (oral semaglutide 25 mg) approval, December 22, 2025; OASIS 4 results (16.6% / 13.6%). novonordisk.com; prnewswire.com
- Novo Nordisk / FDA — Ozempic tablets (1.5/4/9 mg) approval for type 2 diabetes, February 4, 2026; US launch May 4, 2026 (replacing Rybelsus). prnewswire.com; drugs.com
- FDA / Novo Nordisk — Wegovy HD (semaglutide 7.2 mg) approval, March 2026; STEP UP (~21%). fda.gov; drugs.com
- Eli Lilly — Zepbound (tirzepatide) SURMOUNT-1 (16.0%/21.4%/22.5%) and SURMOUNT-5 head-to-head (20.2% vs 13.7%), NEJM 2025. investor.lilly.com
- Novo Nordisk — Wegovy injection STEP 1 (~14.9%); prescribing information (do not combine GLP-1s). novonordisk.com; wegovy.com
- Wegovy pill dosing/fasting rule and oral semaglutide bioavailability. wegovy.com; FDA label
- Compounding status: FDA shortage resolutions (tirzepatide Dec 2024, semaglutide Feb 2025); FDA 503B Bulks List proposal, Federal Register notice 91 Fed. Reg. 23431 (published May 1, 2026), comments due June 30, 2026; FDA concerns on unapproved GLP-1s. FDA; Federal Register
- Pricing: Ro (Zepbound, Foundayo, Ro Body membership $39 first month / $149 / as low as $74 annual prepay; GLP-1 coverage checker); LillyDirect (Zepbound, Foundayo); NovoCare (Wegovy injection $199 through June 30, 2026 then $349; Wegovy HD $399). ro.co; lilly.com; novocare.com
- Medicare GLP-1 Bridge (July 1, 2026–Dec 31, 2027; Part D beneficiaries; $50/month copay; covers all Foundayo, all Wegovy pills and injections, and the Zepbound KwikPen only; prior authorization). CMS
Medical disclaimer: This page is informational and not a substitute for professional medical advice, diagnosis, or treatment. Prices and approvals were verified as of June 2026 and change frequently. GLP-1 medications are prescription drugs with serious risks; talk to a licensed clinician about whether one is right for you. FDA-approved and compounded medications are different and are not interchangeable.
Related guides
The RX Index is an independent editorial publisher. We score GLP-1 providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost. We are not affiliated with Eli Lilly, Novo Nordisk, or any drug manufacturer. We may earn a commission if you visit a provider through our links.